Fig. 5From: Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experienceRBE/CBE-weighted dose (dashed line) compared to iso-effective dose (solid line) as a function of absorbed dose, using RBE factors and model parameters derived from experimental UMR-106 survival curvesBack to article page